Takeda Pharmaceutical Company Limited Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2020-12-17: Form 6-K; Period of report 2020-12-17; Description FORM 6-K; Document form6k-121720.htm.
- 2020-12-08: Form 6-K; Period of report 2020-12-08; Description FORM 6-K; Document form6k-120820.htm.
- 2020-11-30: Form 6-K; Period of report 2020-11-30; Description FORM 6-K; Document form6k-113020.htm.
- 2020-11-24: Form 6-K; Period of report 2020-11-24; Description FORM 6-K; Document form6k-112420.htm.